US drug packaging firm Comar says acquisition of Universal Container Corp (Unicon) provides capacity for growth, particularly in key liquid medication delivery device market.
AMPAC Fine Chemicals boosts reactor capacity 30 per cent with new manufacturing plant and says North America is attractive for API production.
US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).
Silence Therapeutics says extension of RNAi drug delivery collaboration by Dainippon Sumitomo is evidence of technology’s potential.
Industrial glass maker Schott ended a “rather difficult” fiscal 2009 with a loss but says rise in drug packaging sales will help drive double-digit earnings growth in current financial year.
German investment group Aurelius AG has acquired French fine chemicals supplier Isochem from state owned firm Groupe SNPE.
German pharmaceutical firm Merck KGaA says proposed Millipore acquisition will transform its chemicals unit and give it a more balanced business profile.
RecipharmCobra Biologics (RCB) launched today as a specialist biologics contract development and manufacturing organization (CDMO).
Merck & Co says manufacturing and R&D jobs will go as part of the post acquisition workforce reduction programme it announced yesterday.
Icelandic generics firm Actavis says expansion of its tablet plant will boost production capacity 50 per cent and create 50 new jobs.
In a busy week of Big Phama results Pfizer reports sales boost from Wyeth, Roche says Genentech hit profits and GSK unveils surge in Relenza sales and plans to expand R&D restructuring.
Global packaging giant Amcor today announced that its acquisition of Alcan Packaging had been completed as it spelled out what the move would mean for suppliers and customers.
Keller-Crescent has acquired Puerto Rico-based Lehigh Press to expand its capacity for producing pharmaceutical labels, inserts and outserts.
US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.
Recipharm says acquisition of German CMO Wasserburger Arzneimittelwerk from Hospira adds large-scale lyophilisation services to its offering.